BST2 and cancer: Some of these gene candidates are also associated with cancer: TMEM184A is a prognostic marker in cervical squamous cell carcinoma and endocervical adenocarcinoma [41]; GREM2 inhibits cancer progression and is associated with the inhibition of adipogenesis [42], SFN [41], KIR3DX1 [41], HPGD [43], ESR1 [44], BST2 [45]; PIK3CG [41], and RNASE1 [41].